Hyaluronan-Conjugated nanoparticles as carrier of sodium borocaptate for tumor targeting in boron neutron capture therapy
| Project/Area Number |
22791229
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | Hiroshima International University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Keywords | BNCT / メラノーマ / DDS / ヒアルロン酸 / 経皮 |
|---|
| Research Abstract |
We have developed a strategy for targeting sodium borocaptate in melanoma boron neutron capture therapy. The boron-retention capacity of boron formulations was very high. All boborocaptate-loaded nanoparticles had no cytotoxic effects. Hyaluronan-Conjugated nanoparticles readily bound to melanoma cells, and were internalized by receptor-mediated endocytosis. Thermal neutron irradiation yielded tumor growth suppression on B16F10 murine melanoma and COLO679 human melanoma with the Hyaluronan-Conjugated nanoparticles.
|
Report
(3 results)
Research Products
(4 results)
